Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01216358 · ClinicalTrials.gov registry record
Boston Migraine and Contraception Study
A clinical trial, sponsored by Planned Parenthood League of Massachusetts.
- Completed
- Registry status
- 171
- Enrollment target
NCT01216358 is a clinical trial that has completed, run by Planned Parenthood League of Massachusetts. The registered enrollment target is 171 participants.
The verdict
NCT01216358 has completed, sponsored by Planned Parenthood League of Massachusetts.
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
Study Summary
The objectives of this prospective, descriptive study are to: 1. generate estimates of the incidence, prevalence, persistence, clinical impact and attributable risk of migraine due to hormonal contraception (HC) use; and 2. identify predictive factors for clinically significant changes in headache attributable to HC use. The investigators hypothesize that: 1. Most women with pre-existing migraine will have no significant change from baseline headache frequency or clinical impact attributable to HC at 3 months following initiation; a minority will report clinically significant worsening or improvement 2. The incidence of headache and migraine in HC users will not be significantly different from their incidence in NHC users 3. There will be identifiable risk factors for development or worsening of headache/migraine in the minority of HC users where that occurs.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01216358
The ClinicalTrials.gov registry entry for NCT01216358 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Planned Parenthood League of Massachusetts, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01216358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01216358 about?
NCT01216358 is a clinical study titled "Boston Migraine and Contraception Study". The objectives of this prospective, descriptive study are to: 1. generate estimates of the incidence, prevalence, persistence, clinical impact and attributable risk of migraine due to hormonal contraception (HC) use; and 2. identify predictive factors for clinically significant changes in headache ...
What is the current status of trial NCT01216358?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2010-10. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01216358?
This trial is sponsored by Planned Parenthood League of Massachusetts, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.